Ziwei Yang
Research
Publications
2023
Antiviral HIV-1 SERINC restriction factors disrupt virus membrane asymmetry
Leonhardt S, Purdy M, Grover J, Yang Z, Poulos S, McIntire W, Tatham E, Erramilli S, Nosol K, Lai K, Ding S, Lu M, Uchil P, Finzi A, Rein A, Kossiakoff A, Mothes W, Yeager M. Antiviral HIV-1 SERINC restriction factors disrupt virus membrane asymmetry. Nature Communications 2023, 14: 4368. PMID: 37474505, PMCID: PMC10359404, DOI: 10.1038/s41467-023-39262-2.Peer-Reviewed Original Research
2022
Molecular basis for antiviral activity of two pediatric neutralizing antibodies targeting SARS-CoV-2 Spike RBD
Chen Y, Prévost J, Ullah I, Romero H, Lisi V, Tolbert W, Grover J, Ding S, Gong S, Beaudoin-Bussières G, Gasser R, Benlarbi M, Vézina D, Anand S, Chatterjee D, Goyette G, Grunst M, Yang Z, Bo Y, Zhou F, Béland K, Bai X, Zeher A, Huang R, Nguyen D, Sherburn R, Wu D, Piszczek G, Paré B, Matthies D, Xia D, Richard J, Kumar P, Mothes W, Côté M, Uchil P, Lavallée V, Smith M, Pazgier M, Haddad E, Finzi A. Molecular basis for antiviral activity of two pediatric neutralizing antibodies targeting SARS-CoV-2 Spike RBD. IScience 2022, 26: 105783. PMID: 36514310, PMCID: PMC9733284, DOI: 10.1016/j.isci.2022.105783.Peer-Reviewed Original ResearchReceptor-binding domainSARS-CoV-2 patientsK18-hACE2 micePlasma neutralization activitySARS-CoV-2 variantsSARS-CoV-2 spike receptor-binding domainSpike receptor-binding domainProphylactic administrationNAb responsesPediatric patientsPotent NAbsLethal challengeNeutralizing antibodiesNeutralization activityDelta VOCEffector activityAntiviral mechanismAntiviral activityClinical interventionsPatientsNAbsAntibodiesEpitopesMolecular determinantsMolecular basisSARS-CoV-2 Variants Increase Kinetic Stability of Open Spike Conformations as an Evolutionary Strategy
Yang Z, Han Y, Ding S, Shi W, Zhou T, Finzi A, Kwong PD, Mothes W, Lu M. SARS-CoV-2 Variants Increase Kinetic Stability of Open Spike Conformations as an Evolutionary Strategy. MBio 2022, 13: e03227-21. PMID: 35164561, PMCID: PMC8844933, DOI: 10.1128/mbio.03227-21.Peer-Reviewed Original ResearchConceptsSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variantsAngiotensin-converting enzyme 2 receptorHuman angiotensin-converting enzyme 2 (ACE2) receptorVirus entryEnzyme 2 (ACE2) receptorTarget of antibodiesCOVID-19 vaccineSARS-CoV-2S variantsVirus particlesSARS-CoV-2 adaptationConvalescent patientsAntibody therapyAntibody responseImmune evasionE484KD614GSpike glycoproteinHarbor mutationsHuman hostVaccineS glycoproteinPrimary targetSoluble trimersHACE2SARS-Cov-2 variants of concern decelerate the dynamics of spike open conformation as an evolutionary strategy
Yang Z, Han Y, Ding S, Finzi A, Mothes W, Lu M. SARS-Cov-2 variants of concern decelerate the dynamics of spike open conformation as an evolutionary strategy. Biophysical Journal 2022, 121: 39a. PMCID: PMC8833081, DOI: 10.1016/j.bpj.2021.11.2500.Peer-Reviewed Original Research
Academic Achievements & Community Involvement
Get In Touch
Contacts
Email